A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal, Fasiha Kanwal, Diana Romero, Manal F Abdelmalek, Quentin M Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher Byrne, Graciela E Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna CryerKenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D Guy, Stephen A Harrison, Seung Up Kim, Bart Koot, Marko Korenjak, Kris Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R Morgan, Elisabeth Powell, Michael Roden, Manuel Romero-Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia C Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B Vos, Vincent Wai-Sun Wong, Stavra Xanthakos, Yusuf Yilmaz, Zobair Younossi, Ansley Hobbs, Marcela Villota-Rivas, Philip N Newsome, Luca Miele, Group NAFLD Nomenclature consensus

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)N/A-N/A
JournalJournal of Hepatology
DOIs
Publication statusPublished - 2023

Keywords

  • Delphi
  • Fatty liver disease
  • MASLD
  • MetALD
  • NAFLD
  • NASH
  • type 2 diabetes
  • cardiometabolic
  • nomenclature
  • nonalcoholic
  • steatohepatitis
  • steatotic liver disease
  • alcohol

Cite this